Policy & Advocacy.

Submissions

AusBiotech is committed to representing the Australian life science ecosystem and regularly seeks feedback from its members and Advisory Groups, who are key stakeholders of the sector’s industry, research and investment counterparts.

AusBiotech regularly submits commentary on behalf of its members and the Australian life science industry, addressing topics such as the R&D Tax Incentive, intellectual property, medical devices and diagnostics, prostheses listing, agriculture and foodtech. Our commentary is submitted to the Therapeutic Goods Administration (TGA), Productivity Commission, Department of Industry, Science, Energy and Resources, FSANZ and other relevant bodies.

Recent AusBiotech submissions

Date	Topic	Submission Title	Submitted to
10 September 2021	Manufacturing cell and gene therapies	AusBiotech's joint submission to the Economics References Committee’s Inquiry into the Australian Manufacturing Industry	Economics References Committee
16 August 2021	Patent Box	AusBiotech's response to the Australian Patent Box: Treasury Discussion Paper on Policy Design.	Treasury
9 April 2021	Commercialisation	AusBiotech's response to the Department’s University Research Commercialisation consultation paper	Department of Education, Skills and Employment
17 March 2021	Gene technology	AusBiotech's response to the Department of Health's consultation on: Modernising and future-proofing the National Gene Technology Scheme	Department of Health
15 February 2021	Prostheses List	AusBiotech's response to the Department of Health's Consultation Paper: Options for reforms and improvements to the Prostheses List	Department of Health
18 November 2020	Medical devices	AusBiotech’s response to the TGA consultation: Exploring options for the introduction of an Australian Unique Device Identification (UDI) System	Therapeutic Goods Administration
13 November 2020	Medical device reforms	AusBiotech’s feedback on the Benefits Realisation Plan for Medical Device MMDR reforms	Therapeutic Goods Administration
9 November 2020	Medical manufacturing	Australian Medical Manufacturing Exporters Coalition's response to the Medical Manufacturing Roadmap consultation	Department of Industry, Science, Energy and Resources
6 November 2020	Intellectual Property	AusBiotech's response to the Patents Accessibility Review	Department of Industry, Science, Energy and Resources
16 October 2020	Emerging technologies	AusBiotech's response to the Inquiry into approval processes for new drugs and novel medical technologies in Australia	Standing Committee on Health, Aged Care and Sport
7 October 2020	Medical Research and Innovation	AusBiotech submission in response to the Medical Research Future Fund consultation to inform the third Australian Medical Research and Innovation Priorities 2020-2022	Australian Medical Research Advisory Board (AMRAB)
24 August 2020	Pre-budget submission	AusBiotech’s Pre-Budget Submission: Federal Budget 2020-2021	The Treasury
17 August 2020	Regenerative medicine	AusBiotech submission in response to the WHO consultation on: Human Genome Editing: A Draft Framework for Governance	International Council of Biotech Associations
22 May 2020	JobKeeper scheme	AusBiotech submission in response to the Australian Government’s response to the COVID-19 pandemic	Senate Joint Select Committee on the COVID-19 Pandemic
6 March 2020	R&D Tax Incentive	AusBiotech submission in response to the Treasury Laws Amendment (Research and Development Tax Incentive) Bill 2019	Senate Standing Committees on Economics
6 March 2020	R&D Tax Incentive	Health Innovation Collective submission in response to the Treasury Laws Amendment (Research and Development Tax Incentive) Bill 2019	Senate Standing Committees on Economics

View other submissions

• 2019
• 2018
• 2017
• 2016
• 2015
• 2014
• 2013
• 2012

Contact AusBiotech for submissions prior to 2012.